scholarly journals Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

2006 ◽  
Vol 54 (6) ◽  
pp. 1778-1785 ◽  
Author(s):  
Rainer H. Straub ◽  
Peter Härle ◽  
Seizo Yamana ◽  
Takemasa Matsuda ◽  
Kiyoshi Takasugi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 6 ◽  
Antibody Therapy ◽  
Controlled Study ◽  
Adrenal Androgen ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Receptor Antibody ◽  
Interleukin 6 Receptor ◽  
Androgen Secretion

Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis

2006 ◽  
Vol 20 (3) ◽  
pp. 67-68
Author(s):  
Rainer H. Straub ◽  
Peter Harle ◽  
Seizo Yamana ◽  
Takemasa Matsuda ◽  
Kiyoshi Takasugi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 6 ◽  
Antibody Therapy ◽  
Adrenal Androgen ◽  
Receptor Antibody ◽  
Interleukin 6 Receptor ◽  
Androgen Secretion

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial

2004 ◽  
Vol 50 (6) ◽  
pp. 1761-1769 ◽  
Author(s):  
Norihiro Nishimoto ◽  
Kazuyuki Yoshizaki ◽  
Nobuyuki Miyasaka ◽  
Kazuhiko Yamamoto ◽  
Shinichi Kawai ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 6 ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Receptor Antibody ◽  
Interleukin 6 Receptor

A randomized, double-blind, placebo-controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

1995 ◽  
Vol 38 (8) ◽  
pp. 1097-1106 ◽  
Author(s):  
Peter A. Van Der Lubbe ◽  
Ben A. C. Dijkmans ◽  
Hendrik M. Markusse ◽  
Ulla Nässander ◽  
Ferdinand C. Breedveld
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Early Rheumatoid Arthritis ◽  
Antibody Therapy ◽  
Controlled Study ◽  
Monoclonal Antibody Therapy ◽  
Double Blind ◽  
Double Blind Placebo

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

The Lancet ◽  
2008 ◽  
Vol 371 (9617) ◽  
pp. 987-997 ◽  
Author(s):  
Josef S Smolen ◽  
Andre Beaulieu ◽  
Andrea Rubbert-Roth ◽  
Cesar Ramos-Remus ◽  
Josef Rovensky ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 6 ◽  
Randomised Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Receptor Inhibition ◽  
Interleukin 6 Receptor
Sign in / Sign up

Export Citation Format

Share Document